Dioscin inhibits adipogenesis through the AMPK/MAPK pathway in 3T3-L1 cells and modulates fat accumulation in obese mice

Poudel,Barun; Lim,Seong-Won; Ki,Hyeon-Hui; Nepali,Sarmila; Lee,Young-Mi; Kim,Dae-Ki

doi:10.3892/ijmm.2014.1921

Dioscin inhibits adipogenesis through the AMPK/MAPK pathway in 3T3-L1 cells and modulates fat accumulation in obese mice

Authors:
- Barun Poudel
- Seong-Won Lim
- Hyeon-Hui Ki
- Sarmila Nepali
- Young-Mi Lee
- Dae-Ki Kim
View Affiliations

Affiliations: Department of Immunology and Institute of Medical Sciences, Chonbuk National University Medical School, Jeonju, Jeonbuk 561-756, Republic of Korea, Department of Oriental Pharmacy, College of Pharmacy and Wonkwang-Oriental Medicines Research Institute, Wonkwang University, Iksan, Jeonbuk 570-749, Republic of Korea
Published online on: September 4, 2014 https://doi.org/10.3892/ijmm.2014.1921
Pages: 1401-1408

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Dioscin (DS) is a steroidal saponin present in a number of medicinal plants and has been shown to exert anticancer, antifungal and antiviral effects. The present study aimed to deternube the effects DS on the regulation of adipogenesis and to elucidate the underlying mechanisms. In vitro experiments were performed using differentiating 3T3-L1 cells treated with various concentrations (0-4 µM) of DS for 6 days. A cell viability assay was performed on differentiating cells following exposure to DS. Oil Red O staining and triglyceride content assay were performed to evaluate the lipid accumulation in the cells. We also carried out the following experiments: i) flow cytometry for cell cycle analysis, ii) quantitative reverse transcription polymerase chain reaction for measuring adipogenesis-related gene expression, and iii) western blot analysis to measure the expression of adipogenesis transcription factors and AMP-activated protein kinase (AMPK), acetyl-CoA carboxylase (ACC) and mitogen-activated protein kinase (MAPK) phosphorylation. In vivo experiements were performed using mice with obesity induced by a high-fat diet (HFD) that were treated with or without DS for 7 weeks. DS suppressed lipid accumulation in the 3T3-L1 cells without affecting viability at a dose of up to 4 µM. It also delayed cell cycle progression 48 h after the initiation of adipogenesis. DS inhibited adipocyte differentiation by the downregulation of adipogenic transcription factors and attenuated the expression of adipogenesis-associated genes. In addition, it enhanced the phosphorylation of AMPK and its target molecule, ACC, during the differentiation of the cells. Moreover, the inhibition of adipogenesis by DS was mediated through the suppression of the phosphorylation of MAPKs, such as extracellular-regulated kinase 1/2 (ERK1/2) and p38, but not c-Jun-N-terminal kinase (JNK). DS significantly reduced weight gain in the mice with HFD-induced obesity; this was evident by the suppression of fat accumulation in the abdomen. the present study reveals an anti-adipogenic effect of DS in vitro and in vivo and highlights AMPK/MAPK signaling as targets for DS during adipogenesis.

View Figures

View References

1	Kopelman PG: Obesity as a medical problem. Nature. 404:635–643. 2000.PubMed/NCBI
2	Kwon JY, Seo SG, Heo YS, Yue S, Cheng JX, Lee KW and Kim KH: Piceatannol, natural polyphenolic stilbene, inhibits adipogenesis via modulation of mitotic clonal expansion and insulin receptor-dependent insulin signaling in early phase of differentiation. J Biol Chem. 287:11566–115678. 2012. View Article : Google Scholar
3	Green H and Kehinde O: An established preadipose cell line and its differentiation in culture II. Factors affecting the adipose conversion. Cell. 5:19–27. 1975. View Article : Google Scholar : PubMed/NCBI
4	Gregoire FM, Smas CM and Sul HS: Understanding adipocyte differentiation. Physiol Rev. 78:783–809. 1998.PubMed/NCBI
5	Ntambi JM and Young-Cheul K: Adipocyte differentiation and gene expression. J Nutr. 130:3122S–3126S. 2000.PubMed/NCBI
6	He Y, Li Y, Zhao T, Wang Y and Sun C: Ursolic acid inhibits adipogenesis in 3T3-L1 adipocytes through LKB1/AMPK pathway. PLoS One. 8:e701352013. View Article : Google Scholar : PubMed/NCBI
7	Lee JO, Lee SK, Kim JH, et al: Metformin regulates glucose transporter 4 (GLUT4) translocation through AMP-activated protein kinase (AMPK)-mediated Cbl/CAP signaling in 3T3-L1 preadipocyte cells. J Biol Chem. 287:44121–44129. 2012. View Article : Google Scholar : PubMed/NCBI
8	Jones RG, Plas DR, Kubek S, et al: AMP-activated protein kinase induces a p53-dependent metabolic checkpoint. Mol Cell. 18:283–293. 2005. View Article : Google Scholar : PubMed/NCBI
9	Luo Z, Saha AK, Xiang X and Ruderman NB: AMPK, the metabolic syndrome and cancer. Trends Pharmacol Sci. 26:69–76. 2005. View Article : Google Scholar : PubMed/NCBI
10	Song XM, Fiedler M, Galuska D, et al: 5-Aminoimidazole 4-carboxamide ribonucleoside treatment improves glucose homeostasis in insulin-resistant diabetic (ob/ob) mice. Diabetologia. 45:56–65. 2002. View Article : Google Scholar
11	Zhang T, Sawada K, Yamamoto N and Ashida H: 4-Hydroxyderricin and xanthoangelol from Ashitaba (Angelica keiskei) suppresses differentiation of preadipocytes to adipocytes via AMPK and MAPK pathways. Mol Nutr Food Res. 57:1729–1740. 2013.
12	Xiao J, Wang NL, Sun B and Cai GP: Estrogen receptor mediates the effects of pseudoprotodiocsin on adipogenesis in 3T3-L1 cells. Am J Physiol Cell Physiol. 299:C128–C138. 2010. View Article : Google Scholar : PubMed/NCBI
13	Nakamura T, Komori C, Lee Y, Hashimoto F, Yahara S, Nohara T and Ejima A: Cytotoxic activities of solanum steroidal glycosides. Biol Pharm Bull. 19:564–566. 1996. View Article : Google Scholar : PubMed/NCBI
14	Cai J, Liu M, Wang Z and Ju Y: Apoptosis induced by dioscin in Hela cells. Biol Pharm Bull. 25:193–196. 2002. View Article : Google Scholar : PubMed/NCBI
15	Liu MJ, Wang Z, Ju Y, Zhou JB, Wang Y and Wong RN: The mitotic-arresting and apoptosis-inducing effects of diosgenyl saponins on human leukemia cell lines. Biol Pharm Bull. 27:1059–1065. 2004. View Article : Google Scholar : PubMed/NCBI
16	Sata N, Matsunaga S, Fusetani N, Nishikawa H, Takamura S and Saito T: New antifungal and cytotoxic steroidal saponins from the bulbs of an elephant garlic mutant. Biosci Biotechnol Biochem. 62:1904–1911. 1998. View Article : Google Scholar : PubMed/NCBI
17	Ikeda T, Ando J, Miyazono A, et al: Anti-herpes virus activity of Solanum steroidal glycosides. Biol Pharm Bull. 23:363–364. 2000. View Article : Google Scholar : PubMed/NCBI
18	Kwon CS, Sohn HY, Kim SH, et al: Anti-obesity effect of Dioscorea nipponica Makino with lipase-inhibitory activity in rodents. Biosci Biotechnol Biochem. 67:1451–1456. 2003.
19	Song MY, Lv N, Kim EK, et al: Antiobesity activity of aqueous extracts of Rhizoma Dioscoreae Tokoronis on high-fat diet-induced obesity in mice. J Med Food. 12:304–309. 2009. View Article : Google Scholar : PubMed/NCBI
20	Bost F, Aouadi M, Caron L and Binétruy B: The role of MAPKs in adipocyte differentiation and obesity. Biochimie. 87:51–56. 2005. View Article : Google Scholar : PubMed/NCBI
21	Bray GA and Tartaglia LA: Medicinal strategies in the treatment of obesity. Nature. 404:672–677. 2000.PubMed/NCBI
22	Bray GA: A concise review on the therapeutics of obesity. Nutrition. 16:953–960. 2000. View Article : Google Scholar : PubMed/NCBI
23	Christodoulides C and Vidal-Puig A: PPARs and adipocyte function. Mol Cell Endocrinol. 318:61–68. 2010. View Article : Google Scholar : PubMed/NCBI
24	Takahashi S, Tanaka T, Kodama T and Sakai J: Peroxisome proliferator-activated receptor δ (PPARδ), a novel target site for drug discovery in metabolic syndrome. Pharmacol Res. 53:501–507. 2006.
25	Tontonoz P, Hu E and Spiegelman BM: Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor. Cell. 79:1147–1156. 1994. View Article : Google Scholar : PubMed/NCBI
26	Darlington GJ, Ross SE and MacDougald OA: The role of C/EBP genes in adipocyte differentiation. J Biol Chem. 273:30057–30060. 1998. View Article : Google Scholar : PubMed/NCBI
27	Cao Z, Umek RM and McKnight SL: Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells. Genes Dev. 5:1538–1552. 1991. View Article : Google Scholar : PubMed/NCBI
28	Wu Z, Rosen ED, Brun R, et al: Cross-regulation of C/EBP alpha and PPAR gamma controls the transcriptional pathway of adipogenesis and insulin sensitivity. Mol Cell. 3:151–158. 1999. View Article : Google Scholar : PubMed/NCBI
29	Lu C, Zhu W, Shen CL and Gao W: Green tea polyphenols reduce body weight in rats by modulating obesity-related genes. PLoS One. 7:e383322012. View Article : Google Scholar : PubMed/NCBI
30	Warnke I, Goralczyk R, Fuhrer E and Schwager J: Dietary constituents reduce lipid accumulation in murine C3H10 T1/2 adipocytes: a novel fluorescent method to quantify fat droplets. Nutr Metab (Lond). 8:302011. View Article : Google Scholar : PubMed/NCBI
31	Zhang XH, Huang B, Choi SK and Seo JS: Anti-obesity effect of resveratrol-amplified grape skin extracts on 3T3-L1 adipocytes differentiation. Nutr Res Pract. 6:286–293. 2012. View Article : Google Scholar : PubMed/NCBI
32	Yuan G, Jia J, Di L, et al: Effects of C-reactive protein on adipokines genes expression in 3T3-L1 adipocytes. Biochem Biophys Res Commun. 424:462–468. 2012. View Article : Google Scholar : PubMed/NCBI
33	Alvala R, Alvala M, Sama V, Dharmarajan S, Ullas JV and BMR: Scientific evidence for traditional claim of anti-obesity activity of Tecomella undulata bark. J Ethnopharmacol. 148:441–448. 2013. View Article : Google Scholar : PubMed/NCBI
34	Wanders D, Graff EC, White BD and Judd RL: Niacin increases adiponectin and decreases adipose tissue inflammation in high fat diet-fed mice. PLoS One. 8:e712852013. View Article : Google Scholar : PubMed/NCBI
35	Kanagasabapathy G, Malek SN, Mahmood AA, Chua KH, Vikineswary S and Kuppusamy UR: Beta-glucan-rich extract from Pleurotus sajor-caju (Fr.) Singer prevents obesity and oxidative stress in C57BL/6J mice fed on a high-fat diet. Evid Based Complement Alternat Med. 2013:1852592013.PubMed/NCBI
36	Zhang BB, Zhou G and Li C: AMPK: an emerging drug target for diabetes and the metabolic syndrome. Cell Metab. 9:407–416. 2009. View Article : Google Scholar : PubMed/NCBI
37	Tang QQ, Otto TC and Lane MD: Mitotic clonal expansion: a synchronous process required for adipogenesis. Proc Natl Acad Sci USA. 100:44–49. 2003. View Article : Google Scholar : PubMed/NCBI
38	Engelman JA, Lisanti MP and Scherer PE: Specific inhibitors of p38 mitogen-activated protein kinase block 3T3-L1 adipogenesis. J Biol Chem. 273:32111–32120. 1998. View Article : Google Scholar : PubMed/NCBI